144 related articles for article (PubMed ID: 34611311)
1. RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2.
Xu H; Wong CC; Li W; Zhou Y; Li Y; Wang L; Liu L; Yu J
Oncogene; 2021 Nov; 40(47):6513-6526. PubMed ID: 34611311
[TBL] [Abstract][Full Text] [Related]
2. RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.
Liang Q; Ma D; Zhu X; Wang Z; Sun TT; Shen C; Yan T; Tian X; Yu T; Guo F; Tang J; Lin Y; Chen H; Zhou C; Ge Z; Zhong M; Chen J; Liu Q; Wang Z; Fang JY; Chen H; Hong J
Clin Cancer Res; 2018 Mar; 24(6):1473-1485. PubMed ID: 29288235
[No Abstract] [Full Text] [Related]
3. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
Li Q; Wang G; Tao J; Chen W
Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
[TBL] [Abstract][Full Text] [Related]
4. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
5. miR-203a suppresses cell proliferation by targeting RING-finger protein 6 in colorectal cancer.
Miao J; Hou N; Yang W; Jiang Q; Xue W; Wang X; Zhang H; Xiong X; Wang L; Zhao L; Huang C
Anticancer Drugs; 2020 Jul; 31(6):583-591. PubMed ID: 32282367
[TBL] [Abstract][Full Text] [Related]
6. RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3.
Liu L; Zhang Y; Wong CC; Zhang J; Dong Y; Li X; Kang W; Chan FKL; Sung JJY; Yu J
Cancer Res; 2018 Apr; 78(8):1958-1971. PubMed ID: 29374067
[TBL] [Abstract][Full Text] [Related]
7. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
[TBL] [Abstract][Full Text] [Related]
8. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
[TBL] [Abstract][Full Text] [Related]
10. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
[TBL] [Abstract][Full Text] [Related]
11. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
[TBL] [Abstract][Full Text] [Related]
12. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
[TBL] [Abstract][Full Text] [Related]
13. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
[TBL] [Abstract][Full Text] [Related]
14. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
Li Z; Yao H; Wang S; Li G; Gu X
J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
16. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
17. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
[TBL] [Abstract][Full Text] [Related]
20. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
